Sale of IdentiGEN Ltd. to Merck & Co., Inc.

Pegasus Capital has advised Insight Acquisition Holdings Ltd. (“IdentiGEN”) on the sale of the business to Merck Animal Health, a division of Merck & Co., Inc. Dublin-based IdentiGEN is a global leader in DNA-based animal traceability solutions for livestock and aquaculture.

Its DNA TraceBack® solution enables beef, pork, poultry and seafood products to be reliably traced through the food supply chain. Accurate and complete animal traceability solutions provide full accountability, as well as greater transparency, quality and sustainability of food sources for consumers.

The acquisition of IdentiGEN will enable Merck Animal Health to provide end-to-end animal traceability solutions.

“Pegasus early recognised the strategic fit between IdentiGEN and animal health, with their sectoral experience, they helped deliver a great outcome for the Company, staff and shareholders.”

Ciaran Meghen
Founder and Managing Director, IdentiGEN

 
 

identigen.com

  • Year: 2020

  • Sector: Healthcare

  • Terms: Not disclosed


Further Transactions


Previous
Previous

$56m Equity Fundraising for LearnUpon Ltd. from Summit Partners

Next
Next

Sale of Conexim Advisors Ltd. to Irish Life Group